Procurement Summary
Country : Finland
Summary : Lot 3: Claritromycin Oral Suspension 50 Mg/Ml (50 Ml, Oral Suspension Atc J01fa09)
Deadline : 20 Mar 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 114871630
Document Ref. No. : 104047-2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09) - Oral liquid dosage forms - Active pharmaceutical ingredient: Claritromycin - Strength: 50 mg/ml - Pharmaceutical form: 50 ml oral suspension, bottle The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the articles is described in Annex 1. Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Article. The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Doc Title: LOT 3: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09) ...
Document Type: Contract Notice
Reference Number: THL/278/2.02.06/2025
Contract Type: supplies
Authority Type: cga
Doc Title: LOT 3: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09)
Dispatch Date: 2025-02-14
Publish Date: 2025-02-17
Submission Date: 2025-03-20
Documents
Tender Notice